Xiao-Li Chen1, Qin-Rui Hu2, Yu-Jing Bai3, Yu Deng1, Hai-Wei Wang1, Shan Liu1, Yin-Lin Wang1, Yan-Kun Yue4. 1. Department of Ophthalmology, Fuxing Hospital, Capital Medical University, 20 Street of FuXingMenWai, XiCheng District, Beijing, 100038, China. 2. Fujian Provincial Key Laboratory of Ophthalmology and Visual Science, Xiamen Eye Centre of Xiamen University, Eye Institute of Xiamen University, Medical College of Xiamen University, Xiamen, Fujian Province, China. 3. ShenZhen Sibionics Co., Ltd, ShenZhen, China. 4. Department of Ophthalmology, Fuxing Hospital, Capital Medical University, 20 Street of FuXingMenWai, XiCheng District, Beijing, 100038, China. fuxingyk@sina.com.
Abstract
PURPOSE: Neovascular age-related macular degeneration (nAMD) and polypoidal choroidal vasculopathy (PCV) are important vision-threatening diseases worldwide. For effective treatment, the risk factors for the diseases merit investigation. This study aimed to compare the risk factors for nAMD vs. PCV in Chinese patients. METHODS: A total of 946 participants were recruited in this case-control study, including 281 patients with nAMD, 306 patients with PCV, and 359 controls. All participants underwent comprehensive ophthalmic examinations. Information on risk factors were collected by questionnaire. Multivariate logistic regression analyses were performed to investigate the difference in risk factors between nAMD and PCV. In a subgroup of subjects, serum lipid data were obtained and analyzed. RESULTS: Risk factors for nAMD included older age (OR 1.03, P = 0.001), male gender (OR 1.55, P = 0.020), asthma (OR 2.50, P = 0.028), smoking (OR 1.92, P = 0.001), and family history (OR 6.82, P = 0.001), while smoking (OR 1.67, P = 0.013) was the only risk factor for PCV. Compared to patients with PCV, patients with nAMD were more likely to be older and suffer from hyperlipidemia, coronary artery disease, rheumatism, and tumor. Interestingly, higher levels of high-density lipoprotein were positively associated with PCV in the subgroup analysis (OR 7.74, P = 0.011). Besides, results were quite different between the combination of patients with nAMD and PCV and patients with nAMD or PCV alone. CONCLUSIONS: The risk factors for nAMD and PCV is varying with the exception of smoking. Our findings suggest that different strategies might be applied in the clinical management and scientific research on nAMD and PCV.
PURPOSE: Neovascular age-related macular degeneration (nAMD) and polypoidal choroidal vasculopathy (PCV) are important vision-threatening diseases worldwide. For effective treatment, the risk factors for the diseases merit investigation. This study aimed to compare the risk factors for nAMD vs. PCV in Chinese patients. METHODS: A total of 946 participants were recruited in this case-control study, including 281 patients with nAMD, 306 patients with PCV, and 359 controls. All participants underwent comprehensive ophthalmic examinations. Information on risk factors were collected by questionnaire. Multivariate logistic regression analyses were performed to investigate the difference in risk factors between nAMD and PCV. In a subgroup of subjects, serum lipid data were obtained and analyzed. RESULTS: Risk factors for nAMD included older age (OR 1.03, P = 0.001), male gender (OR 1.55, P = 0.020), asthma (OR 2.50, P = 0.028), smoking (OR 1.92, P = 0.001), and family history (OR 6.82, P = 0.001), while smoking (OR 1.67, P = 0.013) was the only risk factor for PCV. Compared to patients with PCV, patients with nAMD were more likely to be older and suffer from hyperlipidemia, coronary artery disease, rheumatism, and tumor. Interestingly, higher levels of high-density lipoprotein were positively associated with PCV in the subgroup analysis (OR 7.74, P = 0.011). Besides, results were quite different between the combination of patients with nAMD and PCV and patients with nAMD or PCV alone. CONCLUSIONS: The risk factors for nAMD and PCV is varying with the exception of smoking. Our findings suggest that different strategies might be applied in the clinical management and scientific research on nAMD and PCV.
Authors: Rogério A Costa; Eduardo V Navajas; Michel E Farah; Daniela Calucci; Jose A Cardillo; Ingrid U Scott Journal: Prog Retin Eye Res Date: 2005-04-18 Impact factor: 21.198
Authors: Usha Chakravarthy; Tien Y Wong; Astrid Fletcher; Elisabeth Piault; Christopher Evans; Gergana Zlateva; Ronald Buggage; Andreas Pleil; Paul Mitchell Journal: BMC Ophthalmol Date: 2010-12-13 Impact factor: 2.209
Authors: Xue Chen; Shi Song Rong; Qihua Xu; Fang Yao Tang; Yuan Liu; Hong Gu; Pancy O S Tam; Li Jia Chen; Mårten E Brelén; Chi Pui Pang; Chen Zhao Journal: PLoS One Date: 2014-09-19 Impact factor: 3.240
Authors: Se Woong Kang; Hoyoung Lee; Kunho Bae; Joo Young Shin; Sang Jin Kim; Jong Min Kim Journal: Graefes Arch Clin Exp Ophthalmol Date: 2016-09-05 Impact factor: 3.117